Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?

To: P.M.Freedman who wrote (1004)	6/9/1999 9:54:00 PM
From: Biomaven	Read Replies (1) \| Respond to of 1686

A company who treasures its own stock for company's stock option plan can be accounted as asset. Not true. Repurchased stock held as treasury stock is never an asset, no matter what purpose it is held for. Conceptually, it is no different (except in its origin of course) from authorized but unissued stock, which is certainly not an asset. With about 50,000 people in the US on Avonex, and well over 200,000 people in the US suffering from relapsing MS, Avonex is a long way from saturating the market. The company's stated goal of 100,000 people on the drug in a few years time seems quite reasonable to me. Peter